Today: 11 April 2026
Oracle stock slips in regular trade despite Goldman buy call as AI buildout stays in focus
13 January 2026
1 min read

Oracle stock slips in regular trade despite Goldman buy call as AI buildout stays in focus

New York, Jan 13, 2026, 10:51 EST — Regular session

  • Oracle shares dropped roughly 1.3% in early trading, lagging despite a recent analyst upgrade.
  • Goldman Sachs upgraded Oracle to “Buy,” setting a $240 price target, citing expected AI-driven cloud market share gains.
  • Investors are zeroing in on funding demands and if new capacity can quickly convert into revenue.

Oracle shares dipped Tuesday despite a bullish shift from Goldman Sachs. Investors remained focused on the short-term strain from the company’s ongoing data-center investments.

Oracle shares slipped 1.3% to $202.10 in early trading.

This matters because Oracle is now a key test of whether the race to expand AI computing power can deliver quick returns—or if spending and financing will outpace profits. Traders have been quick to sell into rallies, particularly when the broader market weakens.

Goldman Sachs raised Oracle’s rating to “Buy” from “Neutral,” setting a $240 price target. The bank highlighted Oracle’s advantage in AI compute workloads and sees its cloud revenue share climbing to around 25% within three years, up from less than 10% today. Analyst Gabriela Borges noted revenue should pick up as more capacity comes online in the 1.2-gigawatt Abilene data-center project, though she cautioned margins might fall short of consensus in the near term. Investing.com

The call centers on Oracle’s push into infrastructure-as-a-service, essentially renting out computing power and storage. This puts Oracle in direct competition with Amazon.com’s AWS, Microsoft’s Azure, and Google’s cloud division, where pricing and capacity often drive deal activity.

Oracle revealed a board shake-up in a recent filing, announcing that directors George H. Conrades and Naomi O. Seligman retired effective immediately after informing the board. The company clarified that neither departure was related to any dispute.

Oracle slipped as U.S. stocks fell, with the SPDR S&P 500 ETF and the Invesco QQQ ETF both trending lower in early trading.

The stock is still finding its footing following December’s steep selloff, triggered when Oracle warned its results would miss estimates and revealed a boost in capital spending. This sparked doubts about how fast AI-driven demand could turn into actual profits.

Income-focused investors have a date coming up soon: Oracle announced a quarterly cash dividend of $0.50 per share. The payment is scheduled for Jan. 23, 2026, following a record date on Jan. 9.

The bigger risk is straightforward. If buildouts drag on, major customers delay deployments, or financing costs climb, the company could endure extended margin pressure beyond what bulls anticipate — and the stock already reflects that risk.

Oracle plans to release its fiscal third-quarter results in mid-March, marking the next major event for investors to watch.

Stock Market Today

  • Merck Shares Show Bullish Pattern With Potential Breakout Ahead
    April 11, 2026, 5:45 PM EDT. Merck's stock is forming an inverse head-and-shoulders pattern, a reliable technical setup signaling a possible bullish breakout above $124. The breakout could push prices toward $135, offering notable upside. This comes amid broader strength in the drug sector, where Merck has consistently converted consolidation phases into gains. Importantly, Merck's quarterly chart reveals historical trends of multi-year rebounds after major pullbacks, suggesting possible long-term gains beyond $134. The stock's interaction with rising weekly moving averages will be critical going forward, as these lines have historically served as support during rallies and resistance when momentum fades. Merck's next earnings report on April 30 could catalyse this setup. Traders and investors should watch for further consolidation to define this pattern before a potential breakout attempt.

Latest article

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

India F-35 Deal Hits Pause: Lockheed Martin Says No Direct Talks, U.S. Door Still Open

11 April 2026
Lockheed Martin said it is not in direct talks with India over the F-35, clarifying that any approach must go through official U.S. and Indian channels under the Foreign Military Sales process. Indian officials confirmed no formal discussions on acquiring the F-35 have begun. India recently approved a $40 billion military upgrade, including other fighter jets, while Lockheed’s F-21 remains in a separate competition.
Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

Why SNOW Stock Is Falling Again: Snowflake Nears 52-Week Low as AI Worries Hit Software

11 April 2026
Snowflake shares fell 8.4% to $121.11 on Friday after an 11.7% drop Thursday, as investors sold off software stocks amid concerns over new AI tools from Anthropic and OpenAI. The stock now trades just above its 52-week low. The S&P 500 Software and Services Index is down 25.5% for the year. Snowflake reported fourth-quarter product revenue of $1.23 billion, up 30% from a year earlier.
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 11.04.2026

11 April 2026
LIVEMarkets rolling coverageStarted: April 11, 2026, 12:00 AM EDTUpdated: April 11, 2026, 5:48 PM EDT Merck Shares Show Bullish Pattern With Potential Breakout Ahead April 11, 2026, 5:45 PM EDT. Merck's stock is forming an inverse head-and-shoulders pattern, a reliable technical setup signaling a possible bullish breakout above $124. The breakout could push prices toward $135, offering notable upside. This comes amid broader strength in the drug sector, where Merck has consistently converted consolidation phases into gains. Importantly, Merck's quarterly chart reveals historical trends of multi-year rebounds after major pullbacks, suggesting possible long-term gains beyond $134. The stock's interaction with
Navitas Semiconductor stock slides 7% as NVTS swings ahead of CEO’s Needham conference slot
Previous Story

Navitas Semiconductor stock slides 7% as NVTS swings ahead of CEO’s Needham conference slot

Palantir stock slips despite Citi upgrade as Feb. 2 earnings loom
Next Story

Palantir stock slips despite Citi upgrade as Feb. 2 earnings loom

Go toTop